Skip to main content
logo
Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
26.13
+0.67 (2.63%)
Oct 27, 2026, 4:00 PM EDT - Market closed

Stoke Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,6861,813584235364883
Market Cap Growth
-4.68%210.31%148.73%-35.46%-58.77%-60.67%
Enterprise Value
1,3341,48932023118652
Last Close Price
26.1331.7411.035.269.2323.99

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
61.129.8315.9826.7529.34-
PB Ratio
4.725.142.551.471.974.05
P/TBV Ratio
4.885.142.551.471.974.05
P/FCF Ratio
-40.36----
P/OCF Ratio
-39.77----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
48.378.078.762.679.51-
EV/FCF Ratio
-33.15----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.020.040.030.02
Debt / FCF Ratio
-0.09----
Net Debt / Equity Ratio
-1.02-1.10-1.06-1.22-1.22-0.99
Net Debt / EBITDA Ratio
1.5920.552.441.732.182.52
Net Debt / FCF Ratio
1.95-8.612.782.356.273.15
Asset Turnover
0.070.540.150.040.05-
Quick Ratio
7.195.065.476.547.3312.83
Current Ratio
7.695.285.816.997.7713.37
Return on Equity (ROE)
-61.10%-2.37%-45.80%-60.80%-50.20%-34.06%
Return on Assets (ROA)
-35.87%-3.73%-25.35%-29.62%-26.36%-20.04%
Return on Capital Employed (ROCE)
-63.50%-5.70%-43.80%-58.10%-46.40%-38.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-12.75%-0.38%-15.23%-44.58%-27.77%-9.72%
FCF Yield
-10.72%2.48%-14.90%-35.20%-9.84%-7.72%
Buyback Yield / Dilution
-7.27%-9.65%-22.76%-13.11%-5.87%-9.71%
SEC Filings: 10-K · 10-Q